Second malignancies after Ewing's sarcoma: Radiation dose-dependency of secondary sarcomas

Journal of Clinical Oncology

Volumn 14, Issue 10, 1996, Pages 2818-2825

  Kuttesch, Jr ^a   Wexler, L H ^a   Marcus, R B ^a   Fairclough, D ^a   Weaver McClure, L ^a   White, M ^a   Mao, L ^a   Delaney, T F ^a   Pratt, C B ^a   Horowitz, M E ^a   Kun, L E ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BASAL CELL CARCINOMA; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RISK; CHILD; DERMATOFIBROMA; EWING SARCOMA; FEMALE; FIBROSARCOMA; HUMAN; LUNG ALVEOLUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; OSTEOSARCOMA; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; RADIATION DOSE; RISK ASSESSMENT; SECOND CANCER; UTERINE CERVIX CARCINOMA IN SITU;

EID: 10144247243     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.10.2818     Document Type: Article

References (40)

1. Blatt J, Copeland DR, Bleyer WA: Late effects of childhood cancer and its treatment, in Pizzo PA, Poplack DG (eds): Principles and Practice of Pediatric Oncology (ed 2). Philadelphia, PA, Lippincott, 1993, pp 1091-1114
2. Meadows AT, Baum E, Fossati-Bellani F, et al: Second malignant neoplasms in children: An update from the Late Effects Study Group. J Clin Oncol 3:532-538, 1985
3. Heyn R, Haeberlen V, Newton WA, et al: Second malignant neoplasms in children treated for rhabdomyosarcoma. J Clin Oncol 11:262-270, 1993
4. Tucker MA, Meadows AT, Boice JD Jr, et al: Cancer risk following treatment of childhood cancer, in Boice JD Jr, Fraumeni JF Jr (eds): Radiation Carcinogenesis: Epidemiology and Biological Significance. New York, NY, Raven, 1984, pp 211-224
5. Hawkins MM, Draper GJ, Kingston JE: Incidence of second primary tumours among childhood cancer survivors. Br J Cancer 56:339-347, 1987
6. de Vathaire F, Francois P, Hill C, et al: Role of radiotherapy and chemotherapy in the risk of second malignant neoplasms after cancer in childhood. Br J Cancer 59:792-796, 1989
7. Olsen JH, Garwicz S, Hertz H, et al: Second malignant neoplasms after cancer in childhood or adolescence. Br Med J 307:1030-1036, 1993
8. Strong LC, Herson J, Osborne BM, et al: Risk of radiation-related subsequent malignant tumors in survivors of Ewing's sarcoma. J Natl Cancer Inst 62:1401-1406, 1979
9. Tucker MA, D'Angio GJ, Boice J, et al: Bone sarcomas linked to radiotherapy and chemotherapy in children. N Engl J Med 317:588-593, 1987
10. Potish RA, Dehner LP, Haselow RE, et al: The incidence of second neoplasms following megavoltage radiation for pediatric tumors. Cancer 56:1534-1537, 1985
11. Tucker MA, Meadows AT, Boice JD, et al: Leukemia after therapy with alkylating agents for childhood cancer. J Natl Cancer Inst 78:459-464, 1987
12. Kaldor JM, Day NE, Clarke EA, et al: Leukemia following Hodgkin's disease. N Engl J Med 322:7-13, 1990
13. Newton WA, Meadows AT, Shimada H, et al: Bone sarcomas as second malignant neoplasms following childhood cancer. Cancer 67:193-201, 1991
14. Pui C, Behm FG, Raimondi SC, et al: Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia. N Engl J Med 321:136-142, 1989
15. Pedersen-Bjergaard J, Daugaard S, Hansen SW, et al: Increased risk of myelodysplasia and leukemia after etoposide, cisplatin, and bleomycin for germ cell tumours. Lancet 338:359-363, 1991
16. Boriani S, Picci P, Sudanese A, et al: Radio-induced sarcomas in survivors of Ewing's sarcoma. Tumori 74:543-551, 1987
17. Smith LM, Cox RS, Donaldson SS: Second cancers in long-term survivors of Ewing's sarcoma. Clin Orthop 274:275 1992
18. Horowitz ME, Kinsella TJ, Wexler LH, et al: Total-body irradiation and autologous bone marrow transplant in the treatment of high-risk Ewing's sarcoma and rhabdomyosarcoma. J Clin Oncol 11:1911-1918, 1993
19. Young MM, Kinsella TJ, Miser JS, et al: Treatment of sarcomas of the chest wall using intensive combined modality therapy. Int J Radiat Oncol Biol Phys 16:49-57, 1989
20. Hayes FA, Thompson EI, Meyer WH, et al: Therapy for localized Ewing's sarcoma of bone. J Clin Oncol 7:208-213, 1989
21. Hayes FA, Thompson EI, Parvey L, et al: Metastatic Ewing's sarcoma: Remission induction and survival. J Clin Oncol 5:1199-1204, 1987
22. Hayes FA, Thompson EI, Hustu HO, et al: The response of Ewing's sarcoma to sequential cyclophosphamide and Adriamycin induction therapy. J Clin Oncol 1:45-51, 1983
23. Meyer WH, Kun L, Marina N, et al: Ifosfamide plus etoposide in newly diagnosed Ewing's sarcoma of bone. J Clin Oncol 10:1737-1742, 1992
24. Miser JS, Kinsella TJ, Triche TJ, et al: Preliminary results of treatment of Ewing's sarcoma of bone in children and young adults: Six months of intensive combined modality therapy without maintenance. J Clin Oncol 6:484-490, 1988
25. Burgert J, Nesbit ME, Garnsey LA, et al: Multimodal therapy for the management of non-pelvic, localized Ewing's sarcoma of bone: An intergroup study (IESS-II). J Clin Oncol 8:1514-1524, 1990
26. Nesbit ME, Gehan EA, Burgert EO, et al: Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: A long-term follow-up of the first intergroup study. J Clin Oncol 8:1664-1674, 1990
27. Marcus RB Jr, Graham-Pole JR, Springfield DS, et al: High-risk Ewing's sarcoma: End-intensification using autologous bone marrow transplantation. Int J Radiat Oncol Biol Phys 15:53-59, 1988
28. Marcus RB, Cantor A, Heare TC, et al: Local control and function after twice-a-day radiotherapy for Ewing's sarcoma of the bone. Int J Radiat Oncol Biol Phys 21:1509-1515, 1991
29. Bader JL, Horowitz ME, Dewan R, et al: Intensive combined modality therapy of small round cell and undifferentiated sarcomas in children and young adults: Local control and patterns of failure. Radiother Oncol 16:189-201, 1989
30. Kalbfleisch JD, Prentice RL: The Statistical Analysis of Failure Time Data. New York, NY, Wiley, 1980
31. Gray RJ: A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 16:1141-1154, 1988
32. Lehmann E: Nonparametrics: Statistical Methods Based on Ranks. San Francisco, CA, Holden-Day, 1975
33. Peto R, Pike MC, Armitage P, et al: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 35:1-39, 1977
34. de Vathaire F, Schweisguth O, Rodary C, et al: Long-term risk of second malignant neoplasm after a cancer in childhood. Br J Cancer 57:448-452, 1987
35. Smith J: Radiation-induced sarcoma of bone: Clinical and radiographic findings in 43 patients irradiated for soft tissue neoplasms. Clin Radiol 33:205-211, 1982
36. D'Angio GJ, Meadows A, Mike V, et al: Decreased risk of radiation-associated second malignant neoplasms in actinomycin-D-treated patients. Cancer 37:1177-1185, 1976
37. Arai Y, Kun LE, Brooks MT, et al: Ewing's sarcoma: Local tumor control and patterns of failure following limited-volume radiation therapy. Int J Radiat Oncol Biol Phys 21:1501-1508, 1991
38. Rosen G, Caparros B, Nirenberg A, et al: Ewing's sarcoma: Ten-year experience with adjuvant chemotherapy. Cancer 47:2204-2213, 1981
39. Bacci G, Toni A, Avella M, et al: Long-term results in 144 localized Ewing's sarcoma patients treated with combined therapy. Cancer 63:1477-1486, 1989
40. Dunst J, Sauer R, Burgers JMV, et al: Radiation therapy as local treatment in Ewing's sarcoma. Cancer 67:2818-2825, 1991